Wolfgang Högler

Also affiliated with Kepler Universitätsklinikum

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document”.

Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad657

N/A

0DataRank · unranked

26 citations

Vivian Szymczuk, Wolfgang Högler, Signe Sparre Beck‐Nielsen, Suma Uday, Nadia Merchant +5 more

Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

JBMR Plus(2024)10.1093/jbmrpl/ziad001

N/A

0DataRank · unranked

20 citations

Wolfgang Högler, Francis H. Glorieux, Anthony A. Portale, Michael P. Whyte, Craig F. Munns +16 more